Navigation Links
Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
Date:4/15/2008

DALLAS, April 15 /PRNewswire/ -- Award-winning actress, Cynthia Nixon, best known for her role as Miranda on the long-running television series Sex and the City, joins Susan G. Komen for the Cure, the world's largest breast cancer advocacy organization, as an Ambassador. Nixon will share her personal experience with breast cancer, attend key events and reach millions through a series of TV and radio Public Service Announcements designed to educate people about the deadly disease and help engage them in Komen for the Cure's global breast cancer movement.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080415/LATU058)

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"Over the next 25 years, an estimated 25 million women around the world will be diagnosed with breast cancer and 10 million could die from the disease," said breast cancer survivor Hala Moddelmog, president and CEO at Komen for the Cure. "Cynthia's personal story will certainly help draw attention to the impact of the disease as she joins the global breast cancer movement and our millions of survivors and activists working daily through Susan G. Komen for the Cure to create a world without breast cancer."

Nixon won an Emmy Award for her work on Sex and the City and a 2006 Tony Award as Best Actress in a leading role for David Lindsay-Abaire's Pulitzer prize-winning play, Rabbit Hole. She stars in the upcoming Sex and the City: The Movie scheduled for release on May 30 by New Line Cinema.

"As the daughter of a breast cancer survivor, knowing my personal risk made me more aware and more empowered when I faced my own diagnosis," said Nixon. "I want to help Susan G. Komen for the Cure educate the 1.1 million women around the globe who face a diagnosis each year. Even if breast cancer doesn't run in your family -- take charge. Talk with your doctor, make healthy lifestyle choices and most importantly, know your body as that can make all the difference in the world."

In a series of intimate Web videos available for viewing at komen.org/cynthia, Nixon will share personal excerpts from her journey. Her candid dialogue serves to empower all to take action in the war on breast cancer.

About Susan G. Komen for the Cure(R)

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested more than $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-877 GO KOMEN.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Transplant Network Appoints Cynthia Siljestrom CEO
2. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
3. Cynthia Steedman Earns Health Care Fraud Investigator Accreditation
4. Mark Leventhal To Address Nixon Peabody LLP
5. Want docs to treat the underserved? Make sure they train at community health centers
6. Expansion of monocyte subset could serve as a biomarker for HIV progressions
7. Western Reserve Heart Care Receives ICANL Nuclear Medicine Accreditation
8. AMERIGROUP Updates 2008 Guidance to Reflect Yesterdays Federal Reserve Action
9. Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers
10. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
11. Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: